BT-A.L vs. AZN
Compare and contrast key facts about BT Group plc (BT-A.L) and AstraZeneca PLC (AZN).
Performance
BT-A.L vs. AZN - Performance Comparison
Loading graphics...
BT-A.L vs. AZN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BT-A.L BT Group plc | 17.41% | 33.10% | 23.69% | 17.70% | -30.23% | 29.97% | -31.28% | -12.15% | -6.56% | -21.99% |
AZN AstraZeneca PLC | 15.10% | 33.09% | 1.12% | -3.63% | 33.30% | 20.79% | 0.09% | 30.52% | 20.61% | 21.59% |
Different Trading Currencies
BT-A.L is traded in GBp, while AZN is traded in USD. To make them comparable, the AZN values have been converted to GBp using the latest available exchange rates.
Fundamentals
BT-A.L:
£20.36B
AZN:
$58.74B
BT-A.L:
£9.54B
AZN:
$48.11B
BT-A.L:
£7.36B
AZN:
$19.83B
Returns By Period
In the year-to-date period, BT-A.L achieves a 17.41% return, which is significantly higher than AZN's 15.10% return. Over the past 10 years, BT-A.L has underperformed AZN with an annualized return of -2.35%, while AZN has yielded a comparatively higher 17.83% annualized return.
BT-A.L
- 1D
- 2.13%
- 1M
- 3.40%
- YTD
- 17.41%
- 6M
- 17.93%
- 1Y
- 35.16%
- 3Y*
- 20.09%
- 5Y*
- 11.76%
- 10Y*
- -2.35%
AZN
- 1D
- 1.99%
- 1M
- 1.85%
- YTD
- 15.10%
- 6M
- 26.17%
- 1Y
- 42.35%
- 3Y*
- 13.57%
- 5Y*
- 19.24%
- 10Y*
- 17.83%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BT-A.L vs. AZN — Risk / Return Rank
BT-A.L
AZN
BT-A.L vs. AZN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for BT Group plc (BT-A.L) and AstraZeneca PLC (AZN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BT-A.L | AZN | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.32 | 1.62 | -0.30 |
Sortino ratioReturn per unit of downside risk | 2.00 | 2.37 | -0.37 |
Omega ratioGain probability vs. loss probability | 1.25 | 1.30 | -0.04 |
Calmar ratioReturn relative to maximum drawdown | 1.52 | 3.40 | -1.88 |
Martin ratioReturn relative to average drawdown | 3.02 | 7.19 | -4.17 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| BT-A.L | AZN | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.32 | 1.62 | -0.30 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.40 | 0.84 | -0.45 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.08 | 0.72 | -0.79 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.11 | 0.55 | -0.45 |
Correlation
The correlation between BT-A.L and AZN is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
BT-A.L vs. AZN - Dividend Comparison
BT-A.L's dividend yield for the trailing twelve months is around 3.80%, more than AZN's 2.62% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BT-A.L BT Group plc | 3.80% | 4.46% | 5.62% | 6.23% | 6.87% | 1.36% | 0.00% | 8.00% | 6.37% | 5.67% | 3.94% | 2.73% |
AZN AstraZeneca PLC | 2.62% | 1.70% | 2.27% | 2.15% | 2.12% | 2.35% | 2.80% | 2.81% | 3.69% | 3.95% | 5.01% | 4.06% |
Drawdowns
BT-A.L vs. AZN - Drawdown Comparison
The maximum BT-A.L drawdown since its inception was -89.98%, which is greater than AZN's maximum drawdown of -37.07%. Use the drawdown chart below to compare losses from any high point for BT-A.L and AZN.
Loading graphics...
Drawdown Indicators
| BT-A.L | AZN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.98% | -48.94% | -41.04% |
Max Drawdown (1Y)Largest decline over 1 year | -19.61% | -12.24% | -7.37% |
Max Drawdown (5Y)Largest decline over 5 years | -43.18% | -27.87% | -15.31% |
Max Drawdown (10Y)Largest decline over 10 years | -72.74% | -27.87% | -44.87% |
Current DrawdownCurrent decline from peak | -38.46% | -2.38% | -36.08% |
Average DrawdownAverage peak-to-trough decline | -47.11% | -11.38% | -35.73% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.87% | 4.88% | +4.99% |
Volatility
BT-A.L vs. AZN - Volatility Comparison
BT Group plc (BT-A.L) has a higher volatility of 9.35% compared to AstraZeneca PLC (AZN) at 7.29%. This indicates that BT-A.L's price experiences larger fluctuations and is considered to be riskier than AZN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| BT-A.L | AZN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.35% | 7.29% | +2.06% |
Volatility (6M)Calculated over the trailing 6-month period | 17.53% | 18.65% | -1.12% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.52% | 26.49% | +0.03% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 29.74% | 22.97% | +6.77% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 30.83% | 24.87% | +5.96% |
Financials
BT-A.L vs. AZN - Financials Comparison
This section allows you to compare key financial metrics between BT Group plc and AstraZeneca PLC. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities